First Horizon Advisors’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7
Closed -$134 2326
2024
Q3
$134 Hold
7
﹤0.01% 2290
2024
Q2
$153 Hold
7
﹤0.01% 2260
2024
Q1
$268 Hold
7
﹤0.01% 2255
2023
Q4
$471 Hold
7
﹤0.01% 2302
2023
Q3
$524 Hold
7
﹤0.01% 2308
2023
Q2
$645 Hold
7
﹤0.01% 2345
2023
Q1
$726 Hold
7
﹤0.01% 2344
2022
Q4
$807 Hold
7
﹤0.01% 2309
2022
Q3
$1K Hold
7
﹤0.01% 2149
2022
Q2
$1K Hold
7
﹤0.01% 2232
2022
Q1
$1K Sell
7
-5
-42% -$943 ﹤0.01% 1600
2021
Q4
$3K Hold
12
﹤0.01% 1891
2021
Q3
$2K Buy
+12
New +$2.95K ﹤0.01% 1995

Other funds holding MED

First Horizon Advisors's MED Position: Q4 2024 in Review

First Horizon Advisors sold out of Medifast (MED) in Q4 2024, closing a stake of 7 shares — an estimated $134 sold.

First Horizon Advisors first reported a position in MED in Q3 2021 and held it in 13 quarters. The position peaked at $3K in Q4 2021. 129 funds tracked by Wall St. Rank hold MED as of Q4 2024.

  • First Horizon Advisors reported no remaining Medifast position as of Q4 2024 after selling out during the quarter.
  • First Horizon Advisors sold 7 Medifast shares in Q4 2024, an estimated $134.
  • First Horizon Advisors first reported a position in Medifast in Q3 2021 and held it in 13 quarters.
  • First Horizon Advisors's Medifast position peaked at $3K in Q4 2021.
  • 129 funds tracked by Wall St. Rank held Medifast as of Q4 2024.

Based on First Horizon Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.